Suzetrigine (VX-548) is an orally active, selective NaV1.8 inhibitor with analgesic properties, also blocking sodium channel protein type 10 subunit alpha. It holds promise for acute pain research, including post-abdominoplasty and bunionectomy pain management. Reagent grade, for research purpose.
Usually ships within 24 hours.